Donald S. Shepard Schneider Institute for Health Policy

      Homepage       Biography       Publications       Projects       Teaching       Downloads       Links
Publications
Books
Articles in Reviewed Journals
Chapters in Books and Proceedings
Monographs
Abstracts, Letters to the editor, etc.
Teaching Cases
Selected Conference Papers and Technical Reports

Articles in Reviewed Journals

  1. Shepard, D.S. A load-shifting model for air pollution control in the electric power industry. Journal of the Air Pollution Control Association 20(11):756-761, 1970.

  2. Kinyanjui, K. and Shepard, D.S. Unemployment among secondary school leavers in Kenya. East Africa Journal 9(8):25-28, 1972.

  3. Shepard, D.S. and Moseley, T.A.E. Mailed versus telephoned appointment reminders to reduce broken appointments in a hospital outpatient department. Medical Care 14(3):268-273, 1976.

  4. Zeckhauser, R.J. and Shepard, D.S. Where now for saving lives? Law and Contemporary Problems 40(4):5-45, 1976.

  5. Shepard, D.S. and Neutra, R. A pitfall in sampling medical visits. American Journal of Public Health 67(8):743-750, 1977.

  6. Weinstein, M.C., Shepard, D.S., and Pliskin, J.S. The economic value of changing mortality probabilities: a decision-theoretic approach. Quarterly Journal of Economics 94(2):373-396, 1980.

  7. Pliskin, J.S., Shepard, D.S., and Weinstein, M.C. Utility functions for life years and health status. Operations Research 28(1):206-224, 1980.

  8. Shepard, D.S. and Thompson, M.S. First principles of cost-effectiveness analysis in health. Public Health Reports 94(6):535-543, 1979. Republished as: Cost-effectiveness analysis in health: first principles for determining resource allocation. Group Practice Journal 30(2):11-13 and 23-26, 1981.

  9. Shepard, D.S. and Zeckhauser, R.J. Long term effects of interventions to improve survival in mixed populations. Journal of Chronic Diseases 33(7):413-433, 1980.

  10. Shepard, D.S. Reliability of blood pressure measurements: implications for designing and evaluating programs to control hypertension. Journal of Chronic Diseases 34(5):191-209, 1981.

  11. Shepard, D.S. and Soule, D.N. Estimating hospital costs by diagnosis for population-based analysis. Journal of Community Health 7(1):2-20, 1981.

  12. Kaufman, S.L. and Shepard, D.S. Costs of neonatal intensive care by day of stay. Inquiry 19(2):167-178, 1982.

  13. [Shepard, D.S.] (Authorship not printed.) Expanded Programme on Immunization: cost-effectiveness. Weekly Epidemiologic Record 57(22):170-173, 1982.

  14. Shepard, D.S. and Finison, L.J. Blood pressure reductions: correcting for regression to the mean. Preventive Medicine 12(2):304-317, 1983.

  15. Steinberg, E.S. and Shepard, D.S. Lead ? is it carcinogenic? Public Health Reviews 11:177-192, 1983.

  16. Shepard, D.S. Estimating the effect of hospital closure on area wide inpatient hospital costs: a preliminary model and application. Health Services Research 18(4):513-549, 1983.

  17. Shepard, D.S. and Zeckhauser, R.J. Survival versus consumption. Management Science 30(4):423-439, 1984.

  18. Shepard, D.S. and Pearlman, L. Healthy habits that pay off. Business and Health 2(4):37-41, 1985.

  19. Lerman, S.J., Shepard, D.S., and Cash, R.A. Treatment of diarrhea in Indonesian children: what it costs and who pays for it. Lancet 2:651-654, 1985.

  20. Shepard, D.S., Sanoh, L., and Coffi, E. Cost-effectiveness of the Expanded Programme on Immunization in the Ivory Coast: a preliminary assessment. Social Science and Medicine 22(3):369-377, 1986.

  21. Simberkoff, M.S., Cross, A.P., Al-Ibrahim, M., Baltch, A.L., Geiseler, P.J., Nadler, J., Richmond, A.S., Smith, R.P., Schiffman, G., Shepard, D.S., and VanEeckhout, J.P. Efficacy of pneumococcal vaccine in high-risk patients. New England Journal of Medicine 315:1318-1327, 1986.

  22. Shepard, D.S. and Cooper, G.S. Small-area variations in rates of hospitalization and surgery within Rhode Island. American Journal of Preventive Medicine 3:101-109, 1987.

  23. Taylor, W.C., Pass, T.M., Shepard, D.S., Komaroff, A.L. Cholesterol reduction and life expectancy: a model incorporating multiple risk factors. Annals of Internal Medicine 106(4):605-614, 1987.

  24. [Zeng-sui, W., Shepard, D.S., et. al.] (Authorship not printed.) Providing deep-well tap water: impact on disease and cost-benefit analysis. Weekly Epidemiologic Record 63, 1988.

  25. Max, E. and Shepard, D.S. Productivity loss due to leprosy in India. International Journal of Leprosy 57 (2):476-482, 1989.

  26. Zeng-sui, W., Shepard, D.S., Yun-cheng, Z., Cash, R.A., Ren-jie, Z., Zhen-xing, Z, and Fu-min, S. Reduction of enteric infectious disease in rural China by providing deep-well tap water. Bulletin of the World Health Organization 67(2):171-180, 1989. (Earlier version also: Development Discussion Paper no. 280, Harvard Institute for International Development, Cambridge, MA, 1989.)

  27. Phonboon, K., Shepard, D.S. Ramaboot, S., Kunasol, P., and Preuksaraj, S. Thailand Expanded Programme on Immunization: the role of immunization sessions and cost-effectiveness. Bulletin of the World Health Organization 67(2):181-188, 1989.

  28. Litvack, J., Shepard, D.S., Quick, J. Setting the price of essential drugs: necessity and affordability. Lancet 2(Aug. 21):376-379, 1989.

  29. Shepard, D.S., Robertson, R., Cameron, C., Saturno, P., Pollack, M., Manceau, J., Meissner, P., Perrone, J. Cost-effectiveness of routine and campaign vaccination strategies in Ecuador. Bulletin of the World Health Organization 67(6):649-662, 1989. [Spanish version: Cost-eficacia de las estrategias de vacunación en servicios ordinarios y en campañas en el Ecuador. Boletín de la Oficina Sanitaria Panamericana 112(2):110-130, 1992.]

  30. Ettling, M.B., Thimasarn, K., Shepard, D.S., Krachaiklin, S. Economic analysis of several types of malaria clinics in Thailand. Bulletin of the World Health Organization 69(4):467-476, 1991.

  31. Kouri, Y.H., Shepard, D.S., Borras, F., Sotomayor, J., Gellert, G.A. Improving the cost-effectiveness of AIDS health care in San Juan, Puerto Rico. Lancet 337(June 8):1397-99, 1991.

  32. Shepard, D.S., Ettling, M.B., Brinkmann, U., Sauerborn, R. The economic cost of malaria in Africa. Tropical Medicine and Parasitology 42(3,Suppl I):199-203, 1991.

  33. Ettling, M.B., Shepard, D.S. Economic cost of malaria in Rwanda. Tropical Medicine and Parasitology 42(3,Suppl I):214-218, 1991.

  34. Sauerborn, R.D., Shepard, D.S., Ettling, M.B., Brinkmann, U., Nougtera, A., Diesfeld, H.J. Estimating the direct and indirect economic costs of malaria in a rural district of Burkina Faso. Tropical Medicine and Parasitology 42(3,Suppl I):219-223, 1991.

  35. Uplekar, M.W., Shepard, D.S. Treatment of tuberculosis by private general practitioners in India. Tubercle 72:284-290, 1991.

  36. Shepard, D.S. The World Bank's Health Sector Priorities Review: Implications for surveillance data. Mortality and Morbidity Weekly Report 41(Supplement):49-55, December, 1992.

  37. Shepard, D.S., Walsh, J., Munar, W., Rose, L., Guerrero, R., Cruz, L.F., Reyes, G., Price, G., Solarte, C. Cost-effectiveness of ambulatory surgery in Cali, Colombia. Health Policy and Planning 8(2):136-142, 1993.

  38. Shepard, D.S. Economic analysis of investment priorities for measles control. Journal of Infectious Diseases 170(Suppl 1)(Nov):S56-S62, 1994.

  39. Stason, W.B., Shepard, D.S., Perry, H.M. Jr, Carmen, B.M., Nagurney, J.T., Rosner, B., Meyer, G. Effectiveness and costs of Veterans Affairs hypertension clinics. Medical Care 32(12):1197-1215, 1994.

  40. Shepard, D.S., Walsh, J.A., Kleinau, E., Stansfield, S., Bhalotra, S. Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach. Vaccine 13(8):707-714, 1995.

  41. Shepard, D.S., Stason, W.B, Perry, H.M., Carmen, B.A., Nagurney J.T. Multivariate cost-effectiveness analysis: an application to optimizing ambulatory care for hypertension. Inquiry 32(3):320-331, 1995.

  42. Callahan, J.J. Jr, Shepard, D.S., Beinecke, R.H., Larson, M.J., Cavanaugh, D. Mental health/substance abuse treatment in managed care: the Massachusetts Medicaid experience. Health Affairs 14(3):173-184, 1995.

  43. Beinecke, R.H., Callahan, J.J. Jr., Shepard, D.S., Cavanaugh, D.A., Larson, M.J. The Massachusetts Mental Health/Substance Abuse Managed Care Program: the providers' view. Administration and Policy in Mental Health 23(5):379-391, 1996.

  44. Beinecke, R.H., Shepard, D.S., Goodman, M. Assessment of the Massachusetts Managed Mental Health/Substance Abuse Program: year three. Administration and Policy in Mental Health 24(5):205-220, 1997.

  45. Shepard, D.S. Expenditures on AIDS in developing countries: patterns and implications [guest editorial]. AIDS Targeted Information 11:R103-R105, 1997.

  46. Shepard, D.S. The cost of AIDS. World Health 50(5):20-21, 1997.

  47. Barona, B.Z., Becerra V.H., Robertson, R.L., Shepard, D.S., Costos de un programa de atención primaria de salud basado en voluntarias. Colombia Médica 28(2):85-91, 1997.

  48. Robertson, R.L., Barona, B.Z., Becerra V.H., Shepard, D.S., Becerra, J., Bongiovanni, A., Essayan, V. Un programa de atención primaria en salud basado en voluntarias en Cali: Metas vs. realidades. Colombia Médica 28(4):167-176, 1997.

  49. Shepard, D.S. Managing medicines: public policy and therapeutic drugs [review of book by Peter Davis]. International Journal for Quality in Health Care 10(2):169, 1998.

  50. Shepard, D.S., Hodgkin D. Cost-effectiveness of intensive treatment of hypertension. The American Journal of Managed Care 4(12 supplement):S765-S770, 1998.

  51. Shepard, Donald S.; Larson, Mary Jo; Hoffmann, Norman G. Cost-effectiveness of substance abuse services: implications for public policy. The Psychiatric Clinics of North America 22(2):385-400, 1999.

  52. Shepard, Donald S.; Anthony, Yvonne A.; Lalta, Stanley; Davis, Karl; McNaught, Allan. Health reform in Jamaica: progress in the hospital sector. Caribbean Health,. 1999 (April); 2(1):12-13. [Reprinted in: The Health Executive: Jamaica Association of Health Service Executives, Vol. 8., No. 1, Oct. 1999, pp. 15-17.]
  53. Ramos-Gomez, Francisco J., Shepard Donald S. Cost-effectiveness model for prevention of early childhood caries. California Dental Association Journal 27(7):539-544, 1999. .

  54. McKay, J.R., Alterman, A.I., Cacciola, J.S., O?Brien, C.P., Koppenhaver, J.M., and Shepard, D.S. Continuing care for cocaine dependence: Comprehensive 2-year outcomes. Journal of Consulting and Clinical Psychology 67:420-427, 1999.

  55. Daley, M., Argeriou, M., McCarty D., Callahan, J. J., Shepard, D. S., Williams, C. N. The costs of crime and the benefits of substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment 19:445-458, 2000.

  56. Shepard, D. S. The employer's perspective [editorial]. American Journal of Managed Care 7(1):85-86, 2001.

  57. Daley, M., Argeriou, J., McCarty D., Callahan J.J., Shepard, D.S., Williams C.N. The impact of substance abuse treatment modality on birth weight and health care expenditures. Journal of Psychoactive Drugs 33(1):57-66, 2001.

  58. Hilton, ME; Maisto, SA; Conigliaro, J; McNeil, M; Kraemer, K; Kelley, ME; Conigliaro, R; Samet, JH; Larson, MJ; Savetsky, J; Winter, M; Sullivan, LM; Saitz, R; Weisner, C; Mertens, J; Parthasarathy, S; Moore, C; Hunkler, E; Hu, T-W; Selby, J; Stout, RL; Zywiak, W; Rubin, A; Zwick, W; Shepard, D. Improving alcoholism treatment across the spectrum of services. Alcoholism: Clinical & Experimental Research 25(1):128-135, 2001.

  59. Beinecke, R., Shepard, D.S., Tetreault J., Hodgkin, D., Marckres, J. Substance abuse providers' assessment of the Massachusetts Behavioral Health Program: year 6. Administration and Policy in Mental Health 28(6):443-457, 2001.

  60. Shepard, D. S. Public-private collaborations in health care: lessons from India, The International Journal for Quality in Health Care 13(4):277-278, 2001.

  61. Shepard, D. S.; Daley, M.; Ritter, G. A.; Hodgkin, D. Effects of a Statewide Carve-Out on Spending and Access to Substance Abuse Treatment in Massachusetts, 1992 to 1996. Health Services Research 36(6), Part II: 32-44, 2001.

  62. Hodgkin, D; Shepard, D. S.; Beinecke, R. H. Management of Outpatient Substance Abuse Treatment by Medical Plans: Michigan Providers’ Experience. Alcoholism Treatment Quarterly 20(1):79-96, 2002.

  63. Shepard, D.S. Evidence-Based Public Health (Commentary): Integrated medical and substance abuse treatment increases abstinence rates for people with substance abuse-related medical conditions. Evidence-Based Healthcare 6(2):51-52, July 2002.

  64. Magura, S.; Horgan, C. M.; Mertens, J. R.; Shepard, D. S. Effects of managed care on alcohol and other drug (AOD) treatment. Alcoholism: Clinical and Experimental Research 26(3):416-422, 2002.

  65. Beinecke, R. H.; Shepard, D. S.; Leung, M.; Sousa, D. Evaluation of the Massachusetts Behavioral Health Program: Year 8. Administration and Policy in Mental Health 30(2):141-158, 2002.

  66. Shepard, D. S., Daley, M., Ritter G., Hodgkin, D., Beinecke, R. Managed care and the quality of substance abuse treatment. The Journal of Mental Health Policy and Economics 5(4): 163-174, 2002.

  67. Shepard, D. S.; Beinecke, R. H.; Reif, S.; Cavanaugh, D. A. Effect of a Managed Care Carve Out on Substance Abuse Treatment in Massachusetts: The Providers’ Perspective. Alcoholism Treatment Quarterly 21(1):63-78, 2003.

  68. Shepard, D.S., Bail, R.N., Merritt, C.G. Cost-effectiveness of USAID’s regional program for family planning in West Africa. Studies in Family Planning 34(2, June) 117-126, 2003.

  69. McKay, J.R., Lynch, K.G., Pettinati, H.M., and Shepard, D.S. An examination of potential sex and race effects in a study of continuing care for alcohol- and cocaine-dependent patients. Alcoholism: Clinical and Experimental Research 27:1321-1323, 2003.

  70. Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R. The health care costs of sarcopenia in the United States. Journal of the American Geriatrics Society 52:80-85, 2004.

  71. Jacobs, E.A, Shepard, D. S., Suaya, J.A., Stone E-L. Overcoming language barriers in health care: costs and benefits of interpreter services. American Journal of Public Health 94(5):866-869, 2004.

  72. Shepard, D.S., Reif, S. The value of vocational rehabilitation: a cost-effectiveness framework. Substance Use and Misuse 39(13&14):2581-2609, 2004.

  73. Daley, M.; Love, C.T; Shepard, D.S.; Peterson, C.; White, K.T.; Hall, F. Cost-effectiveness of Connecticut’s in-prison substance abuse treatment. Journal of Offender Rehabilitation 39(3):69-92, 2004.

  74. Hodgkin, D.; Shepard, D. S.; Anthony, Y. E.; Strickler, G. K. Spending and utilization effects of Michigan Medicaid?s publicly managed substance abuse carve-out. Administration and Policy in Mental Health 31(3):197-217, 2004.

  75. Shepard, D.S., Suaya, J.A., Halstead, S. B., Nathan, M. B., Gubler, D. J., Mahoney, R. T., Wang, D. N. C., Meltzer, M.I. Cost-effectiveness of a pediatric dengue vaccine. Vaccine 22(9-10): 1275-1280, 2004.

  76. McKay J.R., Lynch K.G., Shepard D.S., Ratichek S., Morrison R., Koppenhaver J., Pettinati H.M. The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. Journal of Consulting and Clinical Psychology 72:967-979, 2004.

  77. Shepard, D. S., Daley, M.C., Beinecke, R. H., Hurley, C. L. Managed behavioral health care: lessons from Massachusetts. Administration and Policy in Mental Health 32(4):311-320, March 2005.

  78. Shepard, D. S., Strickler, G. K., McAuliffe, W.E., Beaston-Blaakman, A., Rahman, M., Anderson, T. E. Unmet need for substance abuse treatment of adults in Massachusetts. Administration and Policy in Mental Health 32(4):403-426, March 2005.

  79. McKay, J. R., Lynch, K.G., Shepard, D. S., Pettinati, H. M. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Archives of General Psychiatry 62(2):199-207, 2005.

  80. Shevitz, A.H.; Wilson, I. R.; McDermott A. Y.; Spiegelman, D.; Skinner S.C.; Antonsson, K.; Layne, J.E.; Beaston-Blaakman, A.; Shepard, D.S.; Gorbach, S.L. A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting. Journal of Acquired Immune Deficiency Syndrome 38(4):399-406, 2005.

  81. McKay, J.R., Lynch, K.G., Shepard, D.S., Morgenstern, J., Forman, R.F., Pettinati, H.M. Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders? Addiction 100(2):216-226, 2005.

  82. Daley, M., Shepard, D.S., Bury-Maynard, D. Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions. Substance Use & Misuse 40(3):375-394, 2005.

  83. Shepard, D.S., Calabro, J.A.B., Love, C.T., McKay, J.R., Tetreault, J., Yeom, H.S. Counselor incentives to improve client retention in an outpatient substance abuse aftercare program. Administration and Policy in Mental Health & Mental Health Services Research 33(6):629-635, 2006. Web: http://www.springerlink.com/link.asp?id=x767506r16p25750

  84. Beinecke, R.H.; Shepard, D.S.; Hurley, C.L. Guest editors’ introduction: implementing evidence-based mental health practices and performance measures in Massachusetts. Administration and Policy in Mental Health and Mental Health Services Research 33(6):623-628, 2006. Web: http://www.springerlink.com/link.asp?id=kw274n02665110r1

  85. Bernstein, J., Bernstein, E., Shepard, D.S., Valentine, A., Heeren, T., Winter, M., Levenson, S., Beaston-Blaakman, A., Tassiopoulos, K., Hingson, R. Racial and ethnic differences in health and health care lessons from an inner-city patient population actively using heroin and cocaine. Journal of Ethnicity in Substance Abuse 5(2):35-50, 2006. Web: www.hawthornepress.com

  86. Kanyange, A. R.; Thrivikraman, J.; Shepard, D.S.; Bail, R.N.; Kagubare, J. Managing antiretroviral treatment with a national communication network in Rwanda: Evaluative framework and impacts of TRACnet. Rwanda Medical Journal 65(1):10-14, 2006.

  87. Thrivikraman, J.; Shepard, D.S.; Bail, R.N.; Kagubare, J.; Kanyange, A.R. Managing antiviral treatment with a national communications network in Rwanda: Costs, enhancements, and sustainability of TRACnet. Rwanda Medical Journal 65(1):15-22, 2006.

  88. Shepard, D.S.; Beaston-Blaakman, A.; Kanyange, A.R. Case studies on community-based insurance in Rwanda. Revue Rwandaise, in press.

  89. Halstead, S.B.; Suaya, J.A.; Shepard, D.S. The burden of dengue infection. The Lancet 369(April 28):1410-1411, 2007. R90. Lee, A. J.; Strickler, G.K.; Shepard, D.S. The economics of cardiac rehabilitation: a review of literature. Journal of Cardiopulmonary Rehabilitation and Prevention 27(3):135-142, 2007. Web: http://www.jcrjournal.com

  90. Beaston-Blaakman, A.; Shepard, D.S.; Horgan, C.; Ritter, G. Organizational and client determinations of cost in outpatient substance abuse treatment. The Journal of Mental Health Policy and Economics 10(1):3-13, 2007. Web: www.icmpe.org.

  91. Beaston-Blaakman, A.; Shepard, D.S.; Stone, N.; Shevitz, A.H. Cost-effectiveness of clinical interventions for AIDS wasting. AIDS Care, in press.

  92. Suaya, J.A.; Shepard, D.S.; Chang, M-S.; Caram, M.; Hoyer, S.; Socheat, D.; Chantha, N.; Nathan, M.B. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti. Tropical Medicine and International Health, 12(9):1026–1036, 2007.

  93. Suaya, J.A.; Shepard, D.S., Normand, S.-L.T.; Ades, P,; Prottas, J.; Stason, W.B. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 116:1653-1662, 2007.

  94. Yeom, H.S.; Shepard, D.S. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences. The Journal of Mental Health Policy and Economics 10:165-177, 2007. Web: www.icmpe.org.


Back to Top   |   Updated 12/27/2007 |   Created by Jeremy Maitin-Shepard